startups digital health weight loss glp-1 The Next Frontier in Healthcare Innovation – From to Whole-Body Transformation Q&A: Long-term success of GLP-1

In the SURPASS-2 head-to-head against semaglutide for diabetes, tirzepatide produced significantly greater A1c reductions

Regarding FDA approvals , Mounjaro is primarily approved for managing type 2 diabetes , although it has shown significant weight loss in studies

For patients planning pregnancy, semaglutide should be discontinued at least 2 months before a planned pregnancy due to the long half-life, while tirzepatide may persist for approximately 1 month

Zappy didn't find out about Ousia's licensing problem until December and it ceased its roughly three-month relationship with the pharmacy on Dec

And my work focuses on inflammatory arthritis and specifically the intersection between obesity, metabolic health and immune-mediated disease